|
| Status |
Public on May 01, 2009 |
| Title |
U937 AML1-ETO inducible samples |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
U937 AML cells that express an inducible AML1-ETO construct under the control of the tetracycline promoter.
Microarrays used to discover an AML1-ETO signature for a GE-HTS screen to identify AML1-ETO modulators.
|
| |
|
| Overall design |
U937 AML cells that express an inducible AML1-ETO construct under the control of the tetracycline promoter at 0, 12, 24, 48, and 72 hours and corresponding controls (2 replicates each).
|
| |
|
| Contributor(s) |
Stegmaier K, Corsello SM, Roti G, Ross KN |
| Citation(s) |
19377049 |
| |
| Submission date |
Apr 13, 2009 |
| Last update date |
Jul 08, 2016 |
| Contact name |
Kimberly Stegmaier |
| E-mail(s) |
kimberly_stegmaier@dfci.harvard.edu
|
| URL |
http://www.broad.mit.edu/cancer/
|
| Organization name |
Dana-Farber Cancer Institute and Children’s Hospital Boston
|
| Department |
Department of Pediatric Oncology
|
| Street address |
Harvard Medical School
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02115 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL91 |
[HG_U95A] Affymetrix Human Genome U95A Array |
|
| Samples (16)
|
|
| This SubSeries is part of SuperSeries: |
| GSE15648 |
AML1-ETO induction and knockdown |
|
| Relations |
| BioProject |
PRJNA122931 |
Less...
More...